Progyny CEO Peter Anevski sells 236,630 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Progyny, Inc. CEO Peter Anevski exercised 185,134 stock options on November 10, 2026, at an exercise price of $0.91 per share, acquiring 185,134 common shares; the options were fully vested and exercisable. He also reported four common-stock sale entries totaling 236,630 shares: 120,213 at a weighted-average price of $35.6068 and 64,921 at $36.2851 under a Rule 10b5-1 plan entered into July 2, 2026, plus 33,437 at $35.6067 and 18,059 at $36.2851.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F4 | 185,134 | $0.00 | $0.00 |
| Exercise | Common Stock | 185,134 | $0.91 | $168K |
| Sale | Common Stock F1, F2 | 120,213 | $35.6068 | $4.28M |
| Sale | Common Stock F1, F3 | 64,921 | $36.2851 | $2.36M |
| Sale | Common Stock F2 | 33,437 | $35.6067 | $1.19M |
| Sale | Common Stock F3 | 18,059 | $36.2851 | $655K |
Footnotes (4)
- F1. Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 2, 2026.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- F4. These options are fully vested and exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
fully vested and exercisable technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many options did Peter Anevski have remaining after his PGNY exercise?
What price ranges did PGNY’s reported sales cover?
AI-generated analysis. How Rhea-AI works. Not financial advice.